Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV. (Q34334683)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

object named as

Elias Campo

5

0 references

Randy D Gascoyne

8

object named as

Randy D Gascoyne

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

6

object named as

Wing C Chan

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Andreas Rosenwald

11

object named as

Andreas Rosenwald

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

10

object named as

Elaine S Jaffe

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

12

object named as

Lisa M Rimsza

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Rita M. Braziel

4

object named as

Rita M Braziel

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Sarah T Wilkinson

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Diane R Fernandez

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Shawn P Murphy

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Louis M Staudt

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

1 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1875-1878

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988580

6 July 2018

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988580

6 July 2018

Epigenetic regulation of MHC-II and CIITA genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988580

6 July 2018

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988580

6 July 2018

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988580

6 July 2018

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Mol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988580

6 July 2018

Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988580

6 July 2018

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988580

6 July 2018

Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988580

6 July 2018

Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988580

6 July 2018

Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988580

6 July 2018

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988580

6 July 2018

Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988580

6 July 2018

A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988580

6 July 2018

CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression

1 reference

https://api.crossref.org/works/10.3109%2F10428190903297531

21 January 2018

Identifiers

10.3109/10428190903297531

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34334683&oldid=1858063419"